Artigo

COVID-19 Vaccination and Cardiopulmonary Events After Acute Coronary Syndromes A Secondary Analysis of a Randomized Clinical Trial

André Zimerman

JAMA Network Open., v. 7, n. 5, p. 1-4, 2024.

Motivo: Produção Corpo Clínico

Setor HMV: Clínica Médica

Área da saúde: Cardiologia

Resumo: Introduction COVID-19 vaccines effectively reduce the risk of hospitalizations and death.1,2 However, the efficacy of COVID-19 vaccines in reducing the incidence of cardiopulmonary events in a secondary prevention population at high risk of cardiovascular events remain unstudied, to our knowledge.

Envie um e-mail para os autores